Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Endologix Inc (ELGX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 220,246
  • Shares Outstanding, K 84,710
  • Annual Sales, $ 181,160 K
  • Annual Income, $ -66,400 K
  • 36-Month Beta 0.23
  • Price/Sales 1.22
  • Price/Cash Flow N/A
  • Price/Book 5.51

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/18
See More
  • Average Estimate -0.25
  • Number of Estimates 5
  • High Estimate -0.19
  • Low Estimate -0.33
  • Prior Year -0.11
  • Growth Rate Est. (year over year) -127.27%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.35 +8.09%
on 08/15/18
5.44 -53.31%
on 07/18/18
-2.85 (-52.88%)
since 07/17/18
3-Month
2.35 +8.09%
on 08/15/18
6.72 -62.20%
on 06/15/18
-2.41 (-48.69%)
since 05/17/18
52-Week
2.35 +8.09%
on 08/15/18
6.72 -62.20%
on 06/15/18
-1.72 (-40.38%)
since 08/17/17

Most Recent Stories

More News
Endologix Appoints Jeffrey S. Brown as Chief Operations Officer

Endologix, Inc. (Nasdaq:ELGX) ("Endologix" or the "Company"), a developer and marketer of innovative treatments for aortic disorders, today announced that it has appointed Jeffrey S. Brown...

ELGX : 2.54 (-2.31%)
Endologix (ELGX) Reports Q2 Loss, Tops Revenue Estimates

Endologix (ELGX) delivered earnings and revenue surprises of 5.26% and 0.88%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?

ELGX : 2.54 (-2.31%)
Endologix Reports Second Quarter 2018 Financial Results

Endologix, Inc. (NASDAQ:ELGX), a developer and marketer of innovative treatments for aortic disorders, today announced financial results for the second quarter ended June 30, 2018.

ELGX : 2.54 (-2.31%)
Endologix, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / August 9, 2018 / Endologix, Inc. (NASDAQ: ) will be discussing their earnings results in their Q2 Earnings Call to be held on August 9, 2018 at 4:30 PM Eastern Time.

ELGX : 2.54 (-2.31%)
3 Dental Stocks to Top Earnings Estimates This Season

On upbeat consumer sentiment and increased business investments, the dental supplies industry appears to be in the pink of health now.

ELGX : 2.54 (-2.31%)
XRAY : 38.67 (+1.55%)
CAH : 51.90 (+2.87%)
Free Pre-Market Technical Recap on DENTSPLY SIRONA and Three Additional Medical Supplies Stocks

Stock Research Monitor: ELGX, GKOS, and VLRX

ELGX : 2.54 (-2.31%)
GKOS : 40.17 (+0.45%)
XRAY : 38.67 (+1.55%)
Endologix, Inc. to Announce Second Quarter 2018 Financial Results on August 9, 2018

Endologix, Inc. (Nasdaq: ELGX), a developer and marketer of innovative treatments for aortic disorders, today announced that it will report financial results for the second quarter of fiscal...

ELGX : 2.54 (-2.31%)
Free Technical Research on Valeritas Holdings and Three More Medical Supplies Equities

Stock Research Monitor: DXR, ELGX, and GKOS

VLRX : 1.43 (-1.38%)
ELGX : 2.54 (-2.31%)
DXR : 4.30 (-17.94%)
Market Trends Toward New Normal in Endologix, Sanmina, First American Financial, Expeditors International of Washington, Liberty Broadband, and Nu Skin Enterprises -- Emerging Consolidated Expectations, Analyst Ratings

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Endologix, Inc. (NASDAQ:ELGX),...

EXPD : 74.01 (+0.14%)
ELGX : 2.54 (-2.31%)
FAF : 55.95 (+0.79%)
SANM : 30.20 (+1.00%)
LBRDK : 78.98 (-0.13%)
NUS : 79.75 (+0.69%)
Endologix Reports Positive 1-Year Results from the Ovation(R) LUCY Study

Endologix, Inc. (Nasdaq:ELGX), a developer and marketer of innovative treatments for aortic disorders, announced 1-year results from the LUCY (Evaluation of FemaLes who are Underrepresented...

ELGX : 2.54 (-2.31%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators mostly agree with the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Trade ELGX with:

Business Summary

Endologix, Inc. develops, manufactures and markets products for the treatment of coronary and vascular diseases. A leader in the emerging field of vascular brachytherapy, Endologix, has developed a unique method for the delivery of radiation to prevent restenosis following the interventional treatment...

See More

Key Turning Points

2nd Resistance Point 2.71
1st Resistance Point 2.63
Last Price 2.54
1st Support Level 2.47
2nd Support Level 2.39

See More

52-Week High 6.72
Fibonacci 61.8% 5.05
Fibonacci 50% 4.53
Fibonacci 38.2% 4.02
Last Price 2.54
52-Week Low 2.35

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar